JPH0587518B2 - - Google Patents

Info

Publication number
JPH0587518B2
JPH0587518B2 JP57150627A JP15062782A JPH0587518B2 JP H0587518 B2 JPH0587518 B2 JP H0587518B2 JP 57150627 A JP57150627 A JP 57150627A JP 15062782 A JP15062782 A JP 15062782A JP H0587518 B2 JPH0587518 B2 JP H0587518B2
Authority
JP
Japan
Prior art keywords
dna
hepatitis
hbsag
surface antigen
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57150627A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5856685A (ja
Inventor
Deii Reuinsun Aasaa
Ryuu Chunnchen
Jii Yansuura Danieru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26970555&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH0587518(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of JPS5856685A publication Critical patent/JPS5856685A/ja
Publication of JPH0587518B2 publication Critical patent/JPH0587518B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP57150627A 1981-08-31 1982-08-30 脊椎動物細胞培養におけるポリペプチドの製造方法 Granted JPS5856685A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29823581A 1981-08-31 1981-08-31
US32698081A 1981-12-03 1981-12-03
US326980 1981-12-03
US298235 1999-04-23

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP5189904A Division JP2634371B2 (ja) 1981-08-31 1993-07-30 脊椎動物細胞内でｂ型肝炎表面抗原をコードするｄｎａを発現するベクター

Publications (2)

Publication Number Publication Date
JPS5856685A JPS5856685A (ja) 1983-04-04
JPH0587518B2 true JPH0587518B2 (enExample) 1993-12-16

Family

ID=26970555

Family Applications (3)

Application Number Title Priority Date Filing Date
JP57150627A Granted JPS5856685A (ja) 1981-08-31 1982-08-30 脊椎動物細胞培養におけるポリペプチドの製造方法
JP5189904A Expired - Lifetime JP2634371B2 (ja) 1981-08-31 1993-07-30 脊椎動物細胞内でｂ型肝炎表面抗原をコードするｄｎａを発現するベクター
JP7201034A Expired - Lifetime JP2726641B2 (ja) 1981-08-31 1995-08-07 形質転換脊椎動物細胞の製造方法およびその細胞

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP5189904A Expired - Lifetime JP2634371B2 (ja) 1981-08-31 1993-07-30 脊椎動物細胞内でｂ型肝炎表面抗原をコードするｄｎａを発現するベクター
JP7201034A Expired - Lifetime JP2726641B2 (ja) 1981-08-31 1995-08-07 形質転換脊椎動物細胞の製造方法およびその細胞

Country Status (17)

Country Link
EP (2) EP0291586A3 (enExample)
JP (3) JPS5856685A (enExample)
AU (2) AU555575B2 (enExample)
BR (1) BR8205078A (enExample)
DE (1) DE3280310D1 (enExample)
DK (1) DK173592B1 (enExample)
ES (1) ES515260A0 (enExample)
GB (1) GB2105344B (enExample)
GR (1) GR76906B (enExample)
HK (1) HK29689A (enExample)
HU (1) HU196238B (enExample)
IE (1) IE53873B1 (enExample)
IL (1) IL66637A (enExample)
KE (1) KE3838A (enExample)
NO (1) NO165598C (enExample)
NZ (1) NZ201706A (enExample)
ZW (1) ZW18282A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196194A (en) * 1979-05-24 1993-03-23 The Regents Of The University Of California Vaccines containing Hepatitis B S-protein
US4769238A (en) 1981-08-04 1988-09-06 The Regents Of The University Of California Synthesis of human virus antigens by yeast
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
JPS5936698A (ja) * 1982-08-20 1984-02-28 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えｄｎａおよび形質転換動物細胞
CA1209501A (en) * 1982-09-16 1986-08-12 Nikos Panayotatos Expression vector
US4820642A (en) * 1983-04-04 1989-04-11 The Regents Of The University Of California Amplified expression vector
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
EP0140762A1 (fr) * 1983-10-03 1985-05-08 Transgene S.A. Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application à la préparation d'un vaccin
FR2552776B1 (fr) * 1983-10-03 1986-05-09 Transgene Sa Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application a la preparation d'un vaccin
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
US5639639A (en) * 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US5118627A (en) * 1984-02-27 1992-06-02 Amgen Papova virus construction
FR2560890B1 (fr) * 1984-03-07 1987-10-16 Grp Genie Genetique Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
US4663281A (en) * 1984-03-22 1987-05-05 Mass Institute Of Technology Enhanced production of proteinaceous materials in eucaryotic cells
FR2564106B1 (fr) * 1984-05-09 1988-04-22 Transgene Sa Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix.
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
WO1986006405A1 (fr) * 1985-05-02 1986-11-06 Takeda Chemical Industries, Ltd. Nouveau transformateur et son utilisation
EP0213628A3 (en) * 1985-09-03 1988-09-21 Yeda Research And Development Company, Ltd. Expression of superoxide dismutase in eukaryotic cells
SE8505027D0 (sv) * 1985-10-24 1985-10-24 Kabigen Ab A lytic virulent phage, a hostcell containing same and a process for protein production
EP0228036A3 (en) * 1985-12-18 1988-09-07 Microgenesys, Inc. Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
AU582288B2 (en) * 1986-03-07 1989-03-16 Damon Biotech Inc. Vector and method for achieving high level expression in eukaryotic cells
US5004693A (en) * 1986-07-18 1991-04-02 E. I. Du Pont De Nemours And Company Pseudorabies virus recombinants and their use in the production of proteins
NZ219516A (en) * 1987-02-10 1991-02-26 Wellcome Found Fusion proteins of hbcag (hepatitis b virus core antigen)
US5024939A (en) * 1987-07-09 1991-06-18 Genentech, Inc. Transient expression system for producing recombinant protein
US5443964A (en) * 1987-08-10 1995-08-22 Duke University Poxvirus insertion/expression vector
US5578468A (en) * 1987-08-10 1996-11-26 Duke University Site-specific RNA cleavage
JPH01285196A (ja) * 1988-05-11 1989-11-16 Chisso Corp 発光蛋白エクオリンの製造法
US5709995A (en) * 1994-03-17 1998-01-20 The Scripps Research Institute Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
JP4085231B2 (ja) * 2000-02-28 2008-05-14 株式会社ビークル タンパク質中空ナノ粒子とそれを用いた物質運搬体、ならびに細胞への物質導入方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
US4164565A (en) * 1975-03-14 1979-08-14 New York Blood Center, Inc. Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
FR2444713A1 (fr) 1978-12-18 1980-07-18 Pasteur Institut Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
IN151589B (enExample) 1978-12-22 1983-05-28 Biogen Nv
IE52036B1 (en) 1979-05-24 1987-05-27 Univ California Non-passageable viruses
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
US4399216A (en) * 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811895B (en) * 1980-04-07 1982-04-28 Univ California Expression of hormone genomic clones
FR2480780B1 (fr) * 1980-04-22 1985-12-06 Pasteur Institut Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
DE3176404D1 (en) * 1980-04-22 1987-10-08 Pasteur Institut Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
EP0062574A3 (en) * 1981-03-31 1982-12-29 The Regents Of The University Of California Virus protein synthesis
JPS5813598A (ja) * 1981-06-22 1983-01-26 イーライ・リリー・アンド・カンパニー 組み替えｄｎａクロ−ニング・ベクタ−ならびにその真核細胞性および原核細胞性被形質転換体
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
FR2521165A1 (fr) * 1982-02-08 1983-08-12 Pasteur Institut Fragments d'adn codant pour un peptide immunogene susceptible d'introduire in vivo la synthese d'anticorps anti-poliovirus
US4446235A (en) * 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes

Also Published As

Publication number Publication date
HU196238B (en) 1988-10-28
NZ201706A (en) 1986-05-09
IL66637A (en) 1991-11-21
DK173592B1 (da) 2001-04-09
JPH0937777A (ja) 1997-02-10
ZW18282A1 (en) 1983-03-23
AU8779882A (en) 1983-03-10
KE3838A (en) 1988-12-02
JPS5856685A (ja) 1983-04-04
AU6167186A (en) 1987-01-08
JPH06261748A (ja) 1994-09-20
EP0291586A2 (en) 1988-11-23
EP0073656A2 (en) 1983-03-09
NO165598C (no) 1991-03-06
AU555575B2 (en) 1986-10-02
IL66637A0 (en) 1982-12-31
NO822926L (no) 1983-03-01
JP2634371B2 (ja) 1997-07-23
GB2105344B (en) 1985-10-09
DK386982A (da) 1983-03-01
DE3280310D1 (de) 1991-04-11
EP0073656A3 (en) 1984-10-24
EP0073656B1 (en) 1991-03-06
IE822084L (en) 1983-02-28
GR76906B (enExample) 1984-09-04
ES8401134A1 (es) 1983-12-01
GB2105344A (en) 1983-03-23
IE53873B1 (en) 1989-03-29
ES515260A0 (es) 1983-12-01
AU589673B2 (en) 1989-10-19
BR8205078A (pt) 1983-08-09
HK29689A (en) 1989-04-14
EP0291586A3 (en) 1988-12-07
NO165598B (no) 1990-11-26
JP2726641B2 (ja) 1998-03-11

Similar Documents

Publication Publication Date Title
JPH0587518B2 (enExample)
JP2511394B2 (ja) 酵母菌中でのｂ型肝炎表面抗原の製造
JP2610015B2 (ja) アデノウイルスプロモーターの制御下で所定のポリペプチドをコードしているヌクレオチド配列を含む組換えｄｎａ
JP2573817B2 (ja) ヘテロポリマー系蛋白質の発現ベクターおよび該ベクターを含む細胞
US5314808A (en) Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of a B viral hepatitis, and preparations containing the expression products of said DNAs
US5024938A (en) Recombinant DNA inserted with hepatitis B virus gene, mammalian cells transformed with cloned viral DNA, and production of hepatitis B virus proteins
Liu et al. Direct expression of hepatitis B surface antigen in monkey cells from an SV40 vector
JPH08198897A (ja) ＨＢｓ抗原の免疫原特性を有し、ＨＢｓ抗原により担持されたエピトープに対して外来の抗原部位を担持する粒子及びかかる粒子の産生法
US4741901A (en) Preparation of polypeptides in vertebrate cell culture
JPH0314840B2 (enExample)
US4803164A (en) Preparation of hepatitis b surface antigen in yeast
EP0105141A2 (en) Recombinant DNA molecules, process for their production, their use for production of hepatitis B surface antigen (HBsAg) and pharmaceutical compositions containing this HBsAg
EP0062574A2 (en) Virus protein synthesis
AU4315689A (en) Defective hepadnaviruses and producer cell line for vaccines and treatment of liver diseases and disorders
Denniston et al. Expression of hepatitis B virus surface and e antigen genes cloned in bovine papillomavirus vectors
EP0288198A2 (en) Production of Peptide
JP3305342B2 (ja) Ｂ型肝炎ウイルスタンパク質の製造方法
Feitelson Nucleic acid sequencing of Dane particle DNA and expression of HBV genes
WATANASEREE et al. COS-7 CELLS BY USING A RECOMBINANT pcDNA I VECTOR KRUAVON BALACHANDRA", KASAMA SUPANARANOND", CHUENCHIT
JPH0775545B2 (ja) Ｂ型肝炎表面抗原をコ−ドするベクタ−
JPH01240182A (ja) 新規なＢ型肝炎ウイルス表面抗原産生株ＭＳ１２８、及び該細胞株によるｐｒｅ　Ｓ２蛋白質を含有するＢ型肝炎ウイルス表面抗原を生産する方法
HK1036074A (en) Hepatitis b surface antigen particles